Informative Leaflet About Neovaginal Dilatation After MtF Reassignment Surgery: The Importance of Correct Management of Dilatation Programme

A 35-year-old transgender woman experienced hair regrowth with feminizing HRT, adding dutasteride and bicalutamide, and plans a hair transplant for further improvement. Estrogen also improved skin appearance, and the user advises against cisgender men using feminizing HRT for hair regrowth.

A user shared progress pictures of a corrective hair transplant involving 1670 grafts after a previous unsuccessful surgery. The conversation includes questions about medication use and comments on hairline design.

The post discusses a user's successful hair regrowth using finasteride, dutasteride, topical minoxidil, and estrogen over nine months. The user, who is male-to-female (mtf), reports significant regrowth and no side effects beyond typical hormone replacement therapy effects.

The conversation discusses using estradiol mesotherapy to replicate hormone replacement therapy results while minimizing systemic exposure. It also covers the use of Spironolactone cream, which reportedly has no systemic side effects, and the potential risks of using bicalutamide and Spironolactone in men.

A transgender woman experienced significant hair regrowth after 18 months of hormone replacement therapy (HRT) with estrogen and bicalutamide. The discussion notes HRT's effectiveness for hair regrowth but warns against its use for cisgender men due to feminizing effects.

After gyno removal surgery, the user considers starting finasteride at 0.25 but is concerned about the risk of gyno returning, especially since they previously experienced itchiness with finasteride. They have been using RU58841 at 10% for 2-3 months with unclear effects, and other users share experiences with topical finasteride and discuss the low risk of gyno recurrence.